SPINTARGET
Targeting microtubule polyglutamylation for cancer therapy
Principal Investigator/s
Field / Programme
Quantitative Cell Biology
Quantitative Cell Biology
Summary
Despite huge advances in its detection and treatment, breast cancer (BC) remains the most common malignancy and second most common cause of cancer deaths among women worldwide. This project aims to validate TTLL11 as a novel BC target to develop new drugs that improve the arsenal of current therapies. The uncovering of a new BC targets for treatment as well as its synergistic effects with approved chemotherapies would exert an enormous impact on one of the most deadliest cancers in women.
Despite huge advances in its detection and treatment, breast cancer (BC) remains the most common malignancy and second most common cause of cancer deaths among women worldwide. This project aims to validate TTLL11 as a novel BC target to develop new drugs that improve the arsenal of current therapies. The uncovering of a new BC targets for treatment as well as its synergistic effects with approved chemotherapies would exert an enormous impact on one of the most deadliest cancers in women.
Start: 21/11/2023 End: 21/11/2025
Total Budget: 51.000,00
CRG Budget: 51.000,00
Funded by:
